Web Analytics Made Easy - StatCounter

Hepatitis B Immunoglobulin Inj Tenders

Get complete information related to latest Hepatitis B Immunoglobulin Inj Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Hepatitis B Immunoglobulin Inj Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Hepatitis B Immunoglobulin Inj Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

CTN :45642339 Due date: 01 Aug, 202601 Aug, 2026 20.00 Crore
Tender For procurement of d m - levamisole hcl i.p 75 mg/ml inj., ivermectin i.p 3.1 percent inj., quinapyramine sulphate bp 2 g, quinapyramine prosalt (quinapyramine sulphate b.p 1.5 gm plus quinapyramine chloride b.p 1 gm), each ml containsclosantel 50 mg,benzyl alcohol ip 4percent v/v (as preservative), propylene glycol ip q.s., each ml containsclosantel 50 mg,benzyl alcohol ip 4percent v/v (as preservative), propylene glycol ip q.s., each ml contains ivermectin i.p. 0.9 percent w/v, benzyl alchohol i.p.( as a preservative), each uncoated tablet contains niclosamide piperazine salt 1250 mg excipients qs., albendazole i.p 3 gm/bolus, oxfendazole b.p 2.265 percent w/v suspension, piperzine hexahydrate- 45 percent w/v plus levamisole hydrochloride i.p- 1.5 percent w/v solution, closantel i.p 6 gm/bolus, each uncoated bolus containstriclabendazole- 4 g, fenbendazole- i.p 2 g, each ml contains precipitated sulphur usp 2 mg, benzyl benzoate i.p 0.1 g, lidocaine hcl i.p 2 percent w/v inj, each uncoated tablet containsoxfendazole i.p-375 mg, pyrantel embonate i.p-500 mg, antimony potassium tartrate 2 percent, niclosamide 10percent and levamisole hcl i.p 1.5percent suspension, ampicillin sodium i.p equivalent to anhydrous ampicillin 2 gm plus sterile sulbactam sodium i.p equivalent to anhydrous sulbactam 1 gm, ceftiofur sodium i.p 250 mg inj., procaine penicillin i.p 24 lakh plus penicillin-g sodium 12 lakh plus benzathine penicillin 12 lakh inj., each vial contains sterile ceftiofur soduim i.p eq to anhydrous ceftiofur 1.25mg , each vial (part b) per ml contains n-methyl 2-pyrrolidone 300mg ,benzyl alcohol i.p 10mg ,aqueous base q.s, oxytetracycline hcl ip 120 mg, propylene glycol ip q.s, ceftizoxime ip 3 grams, cefotaxime sodium i.p 500mg inj., ofloxacin ip 10 percent w/ v omidazole ip12 percent w/v, each bolus contains ofloxacin 1000mg,cefixime 1000mg, lactic acid bacillus 120 million spores, each bolus contains halquinol i.p 1.5 gm, each bolus contains ofloxacin 900mg,tindazole 2700mg , dicyclomin 50mg,dimethicon 75mg, enrofloxacin ip 100 mg, ambroxol hydrochloride ip 7.5 mg/ml inj, enrofloxacin i.p 100 mg/ml (long acting) inj., each vail contains enrofloxacin ip (vet) 500mg plus zinc 50mg ( as zinc acetate usp)plus pefloxacin mesilate bp 1500mg ( one ffs ampoule containing swfi ip 20ml ), cefoperazone sodium ip eq to anhydrous cefoperazone 2 gm plus sulbactam sodium usp equivalent to anhydrous sulbactam 1.0 gm, each 4500 mg vial contains cefoperazone sodium ip 3000 mg plus sulbactum sodium usp 1500 mg, trimethoprim i.p 40 mg plus sulphadoxine i.p 200 mg/ml inj., streptomycin sulphate i.p equivalent to 5 g base plus procaine penicillin i.p 30 lakh units plus penicillin g sodium i.p 10 lakh units inj., ofloxacin oral solution ip 10 percent w/v, neomycin sulphate b.p (vet) 5 mg, bacitracin b.p vet 500 i.u cream, gentamicin 0.3 percent w/v , i.p eye drops, each gm contains sulphachlorpyridazine sodium 100mg , trimethoprim ip 20mg, one glass vial contains amoxycillin sodium ip(sterile) equivalent to anhydrous amoxyxillin 3000mg pluspotassium clavulanate ip(sterile) equivalent to clavulanic acid 600mg, streptomycin sulphate 100 mg plus procaine penicillin 1 lakh i.u plus sulphamerazine 500 mg plus hydro cortisone acetate 20 mg, each ml contains levofloxacin hemihydrate equivalent to levofloxacin ip 100 mg plus benzyl alcohol i.p 1.5 percent v/v, water for injection i.p, ofloxacin i.p 0.3 percent , benzalkonium chloride i.p 0.02 percent , ear/eye drops, each 8 g syringe contains cefquinome as sulphate 75 mg, doxycycline 100mg, cefquinome 2.5 percent (each ml contains 25mg), miconazole nitrate ip 2.0 percent w/w plus ofloxacin ip 0.1 percent w/w plus clobetasol propionate ip 0.025 percent w/w, each 3g syringe contains 250 mg of cefalonium dihydrate, each 4 g (60ml when reconstituted as directed) contain cephalexin monohydrate ip equivalent to anhydrous cephalexin 1.5g, serratiopeptidase- 10mg, each ml contains penicillin g procaine ip 300000 unit

Central Government/Public Sector

CTN :45415921 Due date: 30 Jun, 202630 Jun, 2026 NA
Tender For e-tender for procurement of drug items under table-a, for two years from the date of aoc. - amoxicillin trihydrate dispersible tabs. i.p 125mg, amoxycillin 250 mg + cloxacillin 250mg capsule., atropine sulphate inj. i.p. 0.6 mg/ml-1ml amp., azacitidine inj 100 mg /vial, azathioprine 50 mg tab., benzyl benzoate application i.p 25% w/w-500 ml bot., bimatoprost eye drop 0.03%, bupivacaine 0.5% inj - 20ml vial, cabergoline tab 0.5mg, caffeine citrate 1 ml inj per vial/amp, carmustine inj. 100mg/vial, cefotaxime sodium inj. i.p. 125 mg.vial., ceftazidime inj. 1gm./vial, cetuximab inj. 100mg( 5mg/ml) / - 20ml vial, cetuximab inj. 500 mg (5mg/ml)/100ml vial, cilostazol tab ip 50 mg, clopidogrel 75mg tab., daclatasvir 60 mg tab., decitabine inj 50 mg, deferasirox 250mg dispersable tab., desflurence inhalation agent 240 ml, dexamethasone 4 mg tab., dexamethasone tab. i.p. 0.5 mg, diclofenac sod. 50 mg tab., diclofenac sodium injection i.p. 25mg/ml- 3ml amps, digoxin tablet i.p. 0.25 mg, dorzolamide hydrochloride 2.0% eye drop in 5ml, fexofenadine tab 120 mg, fibrin sealent with fast & slow setting of thrombin 1ml, fludarabine inj. - 50mg / 5ml, flurourocil inj. i.p. 250mg. in 5ml. amp., fluticasone nasal spray ip 50 mcg (in maximum of 120 mdi pack), furosemide inj. i.p 20mg/2ml. ampoule, halazone tablet for solution u.s.p. 4mg, human hepatitis b immunoglobulin inj. 200 iu volume in 0.5 ml or 1 ml vial/pfs, ibrutinib 140 mg cap., infliximab inj. 100mg/vial, isosorbide-5-mononitrate 20 mg, isosorbide-dinitrate tab i.p. 5mg., ivermectin 6mg tab., leuprolide depot inj. 22.5 mg/vial, levetiracetam inj. 100 mg /ml in 5ml amps, levofloxacin 500 mg tab., levosalbutamol 1.25 mg + ipratropium bromide 500mcg respules, levosalbutamol oral suspension 1mg/5ml, linezolid infusion 600 mg / 300ml, linezolid syrup 100mg / 5ml, melphalan hcl inj. 50 mg (powder), methotrexate tab 15 mg, naproxen 250mg tab., neostigmine methylsulphate inj.i.p. 0.5mg/ ml - 1ml ampoule, nicorandil tabs 5mg, ondansetron inj. 2mg/ ml in 2ml amp., penicillamine 250 mg. cap., plerixafor inj 24mg/1.2ml per vial, polymixin b sulfate inj. 5,00,000 units/vial, pomalidomide 2mg tab / cap, prednisolone tab.20mg., pyrazinamide tab. i.p. 500mg, pyridostigmine tab 30 mg, risperidone tab. 2 mg, sacubitril + valsartan tab. 50mg, sodium chloride inj 0.45% in polypropelene bottle in ffs technology, sodium fusidate cream / ointment 2%, solifenacin 5mg tab., succinylated polygelline, sulfasalazine tab 500 mg, teicoplanin inj. 200 mg /vial, tetanus toxoid inj. (absorbed) 0.5ml amp. single dose, thiamine 100 mg. inj. per 2ml ampule, tinidazole tab ip 500 mg, tropicamide 0.8% with phenylephrine hydrochloride 5% eye drop, valethamate bromide inj 8 mg/ml in 1ml amp., vecuronium bromide inj. 2mg /ml 2ml vial, important note: 1. all prospective bidders are requested to quote the rate in boq as per accounting unit & item specification as mentioned in the table-a. wrong quoting of the rate in boq will be dealt with as per penal provisions of the t&c of the tender.2. tendered quantity is just a tentative quantity and should not be treated as final. it may increase or decrease, as per need of the state. keeping this in mind, the supplier is not allowed to seek termination of the rate contract after finishing supply of tendered quantity.3. quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period.4. the prospective bidders of the said tender are requested to make a declaration in affidavit under annexure vi(b) in case of sole manufacturer/importer (i.e. proprietary in nature).5. if the item(s) under sole manufacturer / importer is (are) proprietary in nature, quarterly intimation is solicited from the approved bidders positively regarding the status of their item(s) proprietary in nature, otherwise their item(s) will be blocked in the smis.6. in case of tie bid, decision will be taken by the tia as per g.o. no. 2320-f
 Loading, Please wait...

Connect us via What's Up